Carriers of CHIP had a risk of CAD that was 1.9 times higher in comparison with noncarriers (95% CI: 1.4–2.7), and a risk of MI 4 times higher than noncarriers (95% CI: 2.4–6.7). Here, STUB1 is linked to coronary artery disorder.